| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.48 | 0.0003 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |